Bliss Biopharmaceutical (Hangzhou) Co., Ltd
3 clinical trials · Sponsor
◉ Watch Bliss Biopharmaceutical (Hangzhou) Co., Ltd
| Record | Firm | Date |
|---|---|---|
| A First-in-human of Multiplle Doses of BB-1709 in Subjects With Locally Advanced/Metastatic Solid Tumors (NCT06241898) | Bliss Biopharmaceutical (Hangzhou) Co., Ltd | 2023-10-01 |
| A First-in-human of Multiplle Doses of BB-1705 in Subjects With Locally Advanced/Metastatic Solid Tumors (NCT05217693) | Bliss Biopharmaceutical (Hangzhou) Co., Ltd | 2022-06-01 |
| A First-in-human Study of Multiple Doses of BB-1701 in Subjects With Locally Advanced/Metastatic HER2 Expressing Solid Tumors (NCT04257110) | Bliss Biopharmaceutical (Hangzhou) Co., Ltd | 2020-07-28 |
Track Bliss Biopharmaceutical (Hangzhou) Co., Ltd automatically
Every clearance here is in the API, with alerts when new ones post.